Ablynx N.V. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ablynx N.V. with three other
miscellaneous service companies in Europe:
Karo Pharma AB
sales of 657.61 million Swedish Kronor [US$75.67 million]
of the United Kingdom
(£47.62 million [US$64.01 million]
of which 54%
was Clinical Research Service), and
Circassia Pharmaceuticals PLC
based in the United Kingdom
(£46.30 million [US$62.23 million]
of which 59%
During the year ended December of 2017, sales at
Ablynx N.V. were 55.53 million Euro (US$65.41 million).
decrease of 34.8%
versus 2016, when the company's sales were 85.19 million Euro.